Hikma Ventures

Founded in August 2015, Hikma Ventures (HV) operates as the corporate venture capital arm of Hikma Pharmaceuticals. HV will act as an instrument of strategic growth in broadening Hikma's offerings; our primary focus is to identify and invest in emerging companies in the digital health space, globally, that could enhance Hikma's value proposition, reputation and market intelligence. We will also consider investments in other healthcare related areas of current or future strategic interest to Hikma, including drug delivery technologies that have the potential to enhance Hikma's value chain and pipeline. We invest in companies at all stages of development, including start-ups, spinouts, and consortia investments. Our initial investment size is up to $3 million per round. HV looks at global opportunities but with a focus on the US and the Middle East & Africa (MEA). We seek to actively partner with the management teams of portfolio companies to realize the potential of their products and technologies.